Related Experiment Video
Updated: Apr 1, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
Isolation and characterization of novel RECK tumor suppressor gene splice variants
Marina Trombetta-Lima1,2, Sheila Maria Brochado Winnischofer3, Marcos Angelo Almeida Demasi1,2
1Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, SP, 05508-000, Brazil.
Abstract:
Glioblastoma multiforme is the most common and lethal of the central nervous system glial-derived tumors. RECK suppresses tumor invasion by negatively regulating at least three members of the matrix metalloproteinase family: MMP-9, MMP-2, and MT1-MMP. A positive correlation has been observed between the abundance of RECK expression in tumor samples and a more favorable prognosis for patients with several types of tumors. In the present study, novel alternatively spliced variants of the RECK gene: RECK-B and RECK-I were isolated by RT-PCR and sequenced. The expression levels and profiles of these alternative RECK transcripts, as well as canonical RECK were determined in tissue samples of malignant astrocytomas of different grades and in a normal tissue RNA panel by qRT-PCR. Our results show that higher canonical RECK expression, accompanied by a higher canonical to alternative transcript expression ratio, positively correlates with higher overall survival rate after chemotherapeutic treatment of GBM patients. U87MG and T98G cells over-expressing the RECK-B alternative variant display higher anchorage-independent clonal growth and do not display modulation of, respectively, MMP-2 and MMP-9 expression. Our findings suggest that RECK transcript variants might have opposite roles in GBM biology and the ratio of their expression levels may be informative for the prognostic outcome of GBM patients.
Insights
Canonical RECK expression and a higher ratio of canonical to alternative transcripts correlate with better glioblastoma multiforme survival. Alternative RECK variants may promote tumor growth, impacting prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Glioblastoma multiforme (GBM) is an aggressive brain tumor with poor prognosis.
- RECK (Reversion-Inducing Cysteine-Rich Proteinous Knockoff) is known to suppress tumor invasion by inhibiting matrix metalloproteinases (MMPs).
- Previous studies suggest RECK expression correlates with better outcomes in various cancers.
Purpose of the Study:
- To investigate novel alternatively spliced variants of the RECK gene (RECK-B and RECK-I).
- To determine the expression levels and profiles of canonical and alternative RECK transcripts in malignant astrocytomas.
- To assess the prognostic significance of RECK expression and its variants in GBM patients.
Main Methods:
- Isolation and sequencing of novel RECK variants (RECK-B, RECK-I) using RT-PCR.
- Quantification of canonical and alternative RECK transcript expression via qRT-PCR in astrocytoma tissues and normal RNA panels.
- Analysis of RECK-B overexpression effects on U87MG and T98G cell lines, including anchorage-independent growth and MMP expression.
Main Results:
- Higher canonical RECK expression correlates with improved overall survival in GBM patients undergoing chemotherapy.
- An elevated ratio of canonical to alternative RECK transcript expression is associated with better patient prognosis.
- Overexpression of the RECK-B variant in GBM cells enhanced anchorage-independent growth without affecting MMP-2 or MMP-9 levels.
Conclusions:
- Novel RECK transcript variants (RECK-B and RECK-I) have been identified.
- The ratio of canonical to alternative RECK transcript expression may serve as a prognostic biomarker for GBM.
- RECK transcript variants may play opposing roles in GBM pathogenesis, influencing tumor behavior and patient outcomes.
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

